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placement assay useful to determine enantiomeric excess 
(ee) enantiomeric samples calorimetrically. Determination 
may be by inspection of color with the naked eye, spectro 
graphic measurement, or mathematical calculation. Concen 
tration may also be determined. The assay may involve two 
independent absorption measurements. On Suitable group of 
enantiomeric molecules to be assayed include O-hydroxy 
acids. The inherent relationship between the absorbance of 
the indicator-displacement ensemble and the overall con 
centration and ee of the analyte is established through 
solution equilibria. The invention also includes use of the 
assay in drug screening and manufacturing, high throughput 
screening of catalysts and kits for use in conducting assays 
of the invention. 
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1. 
DETERMINING ENANTOMERC EXCESS 
USING INDICATOR-DISPLACEMENT 
ASSAYS 
RELATED PATENT APPLICATION 
This application claims the benefit of U.S. provisional 
application No. 60/537,104 filed Jan. 16, 2004, and entitled 
“Determining Enantiomeric Excess. Using Indicator-Dis 
placement Assays”. 
STATEMENT OF GOVERNMENT INTEREST 
The present invention or aspects thereof were invented in 
whole or in part using finding provided by the National 
Institutes of Health, Grant GM57306. The U.S. Government 
may have certain rights in the invention. 
FIELD OF THE INVENTION 
The invention relates to methods and compositions for 
determining enantiomeric excess of an analyte. More spe 
cifically, the present invention relates to indicator displace 
ment assays to determine the enantiomeric excess of a chiral 
analyte. The concentration of the analyte may be determined 
simultaneously. 
BACKGROUND 
Competitive binding assays are established analytical 
methods in medicinal and clinical chemistry. A typical 
competitive binding assay constitutes a receptor and a 
signaling unit that also serves as a Surrogate Substrate. The 
signaling unit possesses an easily observable and quantifi 
able property, which is modulated in response to competitive 
binding with an analyte. For instance, modulation of absor 
bance or emission, or the ability to catalyze a reaction, are 
common approaches. When the signaling unit is a pH or 
Solvatochromic indicator, the assay is specifically called an 
indicator-displacement assay. 
The advantages of an indicator-displacement assay 
include: 1) the need to covalently incorporate the chro 
mophore or fluorophore into the structures of receptors or 
analytes is eliminated; 2) the indicators are exchangeable; 3) 
the detection mechanism is not directly perturbed by the 
analyte structures; and 4) secondary tuning of sensitivity and 
selectivity is available because of the participation of the 
indicator. The usual molecular recognition driving forces are 
exploited in constructing Successful indicator-displacement 
assays. So far, assays utilizing ion pairing, hydrogen bond 
ing, reversible covalent interactions, metal coordination, and 
combinations of these, have been documented. Many physi 
ologically and environmentally important targets, such as 
phosphate, pyrophosphate, citrate, carbonate, amino acids, 
etc., can now be detected and quantified through indicator 
displacement assays. Despite the Successes, the available 
applications of indicator-displacement assays have been 
limited to sensing the identity and quantity of given analytes. 
Indicator-displacement assays have been used in a number 
of sensing applications, but not in quantification of enantio 
meric excess (ee) of a chiral analyte. 
However, there is a growing demand for methods of ee 
determination. For example, the FDA currently requires that 
pharmaceutical companies create enantiomerically pure Sub 
stances, or that the enantiomer of the drug be thoroughly 
studied and found to have no adverse side effects. The 













use of reagents that produce an enantiomeric excess (ee) of 
the desired drug enantiomer or its chemical precursor. High 
throughput Screening for Such enantioselective reagents 
entails product-analyzing assays for rapid determination of 
both the yields and ees from given catalytic reactions. This 
double-parameter requirement increases the difficulty of 
assay design. Traditional enantioselective optical chemosen 
sors, such as BINOL based compounds (-)-6 and 7 in FIG. 
10, usually rely upon cumbersome empirical ee calibration 
curves against absorbance or fluorescence intensity for each 
total concentration of the chiral analyte. Thus a need exists 
for assays capable of rapidly and accurately determining the 
concentrations and ees of chiral samples. 
SUMMARY OF THE INVENTION 
The present invention relates to methods and composi 
tions for analyzing chiral samples with unknown concen 
trations and enantiomeric excesses using enantioselective 
indicator-displacement assays. These assays may be applied 
to analysis of samples comprising C-hydroxycarboxylates, 
vicinal diols, and amino acids. Without being limited to any 
particular mechanism of action, the chemical basis for the 
assays may be the enantioselective, reversible covalent 
associations between chiral boronic acid receptors and chiral 
analytes. In addition, metal coordination may be used as the 
primary associative interaction. In some embodiments of the 
invention, calorimetric or fluorescent indicators may consti 
tute the reporting module of the assays, and act as secondary 
tuning units for the enantioselectivity (chiral resolution) and 
sensitivity of the assays. Specifically, fluorescent indicator 
4-methylesculetin (ML) and calorimetric indicators pyrocat 
echol violet (PV) and alizarin complexone (AC) may pro 
vide a broad dynamic range where the enantioselective 
indicator displacement assays are effective in analyzing 
chiral C-hydroxyacid and diol samples. 
In some embodiments of the invention, a mathematical 
analysis may be applied to the displacement system to 
enable the rapid concurrent determinations of the aforemen 
tioned two parameters. An iterative curve fitting program 
was created according to the teachings of the invention. This 
program enabled the determination of association constants 
between a chiral receptor and its enantiomeric substrates by 
iterative fitting of absorbance (or fluorescence intensity) vs. 
ee curves with the commercial software Origin. The inven 
tion contemplates the use of a plurality of approaches to 
determine association constants between receptors and ana 
lytes including, without limitation, (a) traditional competi 
tive binding method, (b) iterative fitting of competitive 
binding curves with enantiomeric pure analytes, and (c) 
iterative fitting of A (or F) vs. ee curves at fixed total 
concentrations, respectively. In some nonlimiting embodi 
ments of the invention, iterative fitting of A (or F) vs. ee 
curves at fixed total concentrations may be best suited for the 
unknown chiral sample analysis. 
Some assays of the present invention may be faster, 
simpler, and more economical than present screening assays, 
such as HPLC. Further they may not require substrate 
derivatization because they rely on the simple analytical 
technique of absorption spectroscopy. Additionally, the pro 
duction of chiral receptors does not require lengthy synthe 
ses. Finally, the mathematical analysis used may eliminate 
the need for empirical ee calibration curves for each analyte 
concentration. 
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BRIEF DESCRIPTION OF THE DRAWINGS 
The patent application file contains at least one drawing 
executed in color. Copies of this patent or patent application 
publication with color drawing(s) will be provided by the 
United States Patent and Trademark Office upon request and 
payment of the necessary fee. Specific embodiments of the 
present invention are further described in the following 
detailed description taken in conjunction with the accom 
panying drawings. 
FIG. 1 illustrates chemical structures of various com 
pounds that may be used in connection with specific 
embodiments of the present invention. 
FIG. 2 illustrates a general reaction using pyrocatechol 
violet and a boronic acid receptor to determine the concen 
tration or the concentration and ee according to the teachings 
of the present invention. 
FIG. 3 presents graphically the absorbance change at 520 
nm of PV (149 uM) and receptors Compound (S,S)-2 (0.510 
mM), or Compound 1 (0.575 mM) in a default buffer with 
increasing concentration of D- or L-PL (analytes). 
FIG. 4 presents graphically the absorbance change at 520 
nm of PV, receptor, and analyte solutions upon increasing ee 
of D-PL. Black diamonds: I-149 uM, H, Compound (S,S)- 
2=0.51 mM, G=1.50 mM; Blue diamonds: I-149 uM, H, 
Compound (S,S)-2=0.51 mM, G, 3.00 mM; Red dia 
monds: I-141 mM. H. Compound (R,R)-2-0.52 mM, 
G=1.50 mM. Open diamonds: calculated data. 
FIG. 5A presents absorbance spectra of PV (149 uM) in 
75% methanolic aqueous solution buffered with 10 mM 
HEPES at pH 7.4 in the presence of 0-1.3 mM of Compound 
1 
FIG. 5B presents graphically the curve fitting of absor 
bance change vs. receptor concentration at 520 nm (Origin(R) 
5.0). 
FIG. 6A presents absorbance spectra of PV (149 uM) and 
Compound (S,S)-2 (0.510 mM) in 75% methanolic aqueous 
solution buffered with 10 mM HEPES at pH 7.4 in the 
presence of 0-0.15 mM of D-PL. 
FIG. 6B presents graphically a S/P vs. Q plot for com 
petitive binding method with data at 520 nm. 
FIG. 7A presents absorbance spectra of PV (149 uM) and 
Compound (S,S)-2 (0.510 mM) in 75% methanolic aqueous 
solution buffered with 10 mM HEPES at pH 7.4 in the 
presence of 0-0.15 mM of L-PL. 
FIG. 7B graphically presents a S/P vs. Q plot for 
competitive binding method with data at 520 nm. 
FIG. 8A presents absorbance spectra of PV (149 uM), 
Compound (S,S)-2 (0.510 mM) and PL (3.00 mM) in 75% 
methanolic aqueous solution buffered with 10 mM HEPES 
at pH 7.4 with the ee of D-PL changes from -1 to 1. 
FIG. 8B graphically presents the absorbance change at 
520 nm in the ee (of D-PL) range from -1 to 1. Red 
diamonds: ee from -1 to 0; blue square: ee from 1 to 0. 
Matched UV-vis cuvettes were used in the measurements. 
FIG. 9A presents absorbance change at 520 nm of PV 
(149 uM) and Compound 1 (0.575 mM) in 75% methanolic 
aqueous solution buffered with 10 mM HEPES at pH 7.4 
with increasing concentration of D-PL. The experimental 
data was fitted empirically to a polynomial equation: y–3E 
08x-3E-06x+0.0001x-0.0022x+0.0245x-0.164x+ 
1.2123 (R=1). The absorption data of unknown PL samples 
with the indicator-displacement ensemble containing achiral 
receptor Compound 1 were input to the equation above, 
which was solved in Methamatica(R) 5 to afford the overall 













FIG.9B was created in same manner as FIG. 8A, but with 
L-PL. The empirical fitting equation is: y=3E-08X-3E 
06x+0.0001x-0.0021x+0.0236x-0.1592x+1.1959 
(R=1). The absorption data of the unknown PL sample were 
input to the equation above to afford another overall con 
centration. 
FIG. 10 illustrates some enantioselective chemosensors 
for various analytes that may be used in connection with 
specific embodiments of the present invention and that may 
be detected through fluorescence spectroscopy (compounds 
(-)-6, 7, and 8), or proton nuclear magnetic resonance 
spectroscopy (NMR) (9 and 10). 
FIG. 11 illustrates structures of hosts/receptors (H), indi 
cators (I), and selected guests/analytes (G) according to the 
present invention, in which receptor structures are drawn 
with presumptive B N bonds. 
FIG. 12 illustrates enantioselective indicator-displace 
ment assays in accordance with the teachings of the present 
invention for C-hydroxycarboxylates based upon (1) a colo 
rimetric indicator (PV) and (2) a fluorescent indicator (ML). 
FIG. 13A illustrates fluorescence spectra of ML (3.6 mM) 
in 75% methanolic aqueous solution buffered with 10 mM 
HEPES at pH 7.4 (default buffer) in the presence of 0-40 
mM 13. Fluorescence intensity (F) is shown as counts per 
second (CPS). 
FIG. 13B illustrates curve fitting of relative fluorescence 
intensity vs. receptor (13) concentration at 446 nm (excited 
at 362 nm), F, fluorescence intensity of the unbound 
indicator ML. 
FIG. 13C illustrates fluorescence spectra of ML (3.6 mM) 
and 13 (31.9 mM) in the default buffer in the presence of 
0-1.5 mM of L-PL. 
FIG. 13D illustrates an S/P vs. Q plot from the competi 
tive fluorimetric method, derived from the competitive spec 
trophotometric method, with data taken at 446 mm. 
FIG. 14A illustrates fluorescence quenching profiles at 
446 nm of ML (3.6 mM) and receptors (S,S)-15 (34 mM), 
or 13 (31.9 mM) in the default buffer (footnote, FIG. 12) 
with increasing concentration of D- or L-PL, displayed in a 
Stem-Volmer format. Data are shown as the averages of two 
measurements. F. Fluorescence intensity (CPS); Fo Fluo 
rescence intensity (CPS) at the inception. 
FIG. 14B illustrates relative fluorescence intensity change 
at 446 nm of ML (3.6 mM), receptor (S,S)-15 (34 mM), and 
analyte solutions upon increasing ee of D-PL. F. fluores 
cence intensity (CPS) of the free indicator at the designated 
concentration (see the next section); red; G=676 mM: 
blue: G =1.2 mM. The solid lines are theoretical curves 
resulted from iterative data fitting. The association constants 
extracted from the fitting are (averages from two total 
concentrations): K-(3.39-0.03)Y 10 M'; K=(9.79:-0.48) 
Y1O Mil. 
FIG. 15A illustrates the absorbance at 520 nm of PV (149 
mM) and receptor (S,S)-15 (0.51 mM) in the default buffer 
(FIG. 3, footnote) with increasing concentration of D-PL: 
solid line: theoretical curve from iterative fitting in Origin 
with a user defined function. 
FIG. 15B illustrates the fluorescence intensity (F/F) of 
ML (3.6 mM) and receptor 13 (31.9 mM) in the default 
buffer with increasing concentration of L-PL: solid line: 
theoretical curve from iterative fitting in Origin with a user 
defined function. 
FIG. 16A illustrates an absorption spectra of PV (149 
mM) and (S,S)-15 (0.51 mM) in the default buffer (footnote, 
FIG. 3) in the presence of 0-10 mM of (R,R)-HB. 
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FIG. 16B illustrates an absorption spectra of PV (149 
mM) and (S,S)-15 (0.51 mM) in the default buffer in the 
presence of 0-10 mM of (S,S)-HB. 
FIG. 16C illustrates an absorbance change at 520 nm of 
PV (149 mM) and receptors (S,S)-15 (0.51 mM), or 11 (0.82 
mM) in the default buffer with increasing concentrations of 
(R,R)- or (S,S)-HB. 
FIG. 16D illustrates the absorbance at 520 nm of PV (149 
mM), (S,S)-15 (0.51 mM), and HB solutions upon increas 
ingee of (R,R)-HB, blue: G =15 mM, red: G-7.5 mM. 
Solid lines are theoretical curves generated from iterative 
data fitting. The association constants extracted from the 
fittings are (the average from two total concentrations): 
K=387+15 M ; K=1136+78 M'. 
FIG. 17A illustrates the absorbance change at 520 nm of 
PV (149 mM) and receptor 11 (0.82 mM) in the default 
buffer (footnote, FIG. 12) with increasing concentrations of 
L-PL (blue) and PP (red); K-1.2 10 M'. 
FIG. 17B illustrates the absorbance change at 520 nm of 
PV (149 mM) and receptor 6 (0.82 mM) in the default buffer 
with increasing concentrations of L-LC (blue) and PVA 
(red); K=1.0 10 M', K-300 M'. 
FIG. 17C illustrates the absorbance change at 520 nm of 
PV (149 mM) and receptor 6 (0.82 mM) in the default buffer 
with increasing concentrations of S-MD (blue) and BF (red). 
The association constants between pyruvic acids (PP and 
PVA) and 6 were estimated with the competitive spectro 
photometric method, because their binding behaviors are 
also Subject to processes other than Solution equilibria. 
FIG. 18 illustrates the keto-enol tautomerization of phenyl 
pyruvic acid (PP) leads to its association with boronic 
receptors such as 6. 
FIG. 19A illustrates UV-vis spectral modulations for the 
addition of D and L valine into a solution of PV (44 uM) and 
(S,S)-22-Cu (332 uM). 
FIG. 19B illustrates a displacement isotherm at 653 nm 
for the addition of D and L valine into a solution of PV (44 
uM) and (S,S)-22-Cu'(332 uM). 
FIG. 19C illustrates a displacement isotherm at 653 nm 
for the addition of D and L valine to a solution of PV (42 uM), 
Cu(OTf), (341 uM) and (S,S)-22 (2.45 mM). Titrations 
performed in 1:1 MeOH:HO 50 mM HEPES buffer, 
pH=7.0. 
FIG. 20A illustrates the absorbance at 645 nm as a 
function of ee for Leu (6.6 mM) in a solution of PV (75 uM), 
Cu(OTf), (590 uM) and 1 (both enantiomers) (4.2 mM). All 
ee curves were obtained in 1:1 MeOH:HO 50 mM HEPES 
buffer, pH=7.0. 
FIG. 20B illustrates the absorbance at 645 nm as a 
function of ee for Val (7.1 mM) in a solution of PV (75uM), 
Cu(OTf), (590 uM) and (S,S)-22 (4.2 mM). 
FIG. 20O illustrates the absorbance at 645 nm as a 
function of ee for Phe (3.0 mM) in a solution of PV (72 uM), 
Cu(OTf), (590 uM) and (S,S)-22 (4.2 mM). 
FIG. 20D illustrates the absorbance at 645 nm as a 
function of ee for Typ (4.5 mM squares, 3.0 mM diamonds) 
in a solution of PV (90 uM), Cu(OTf), (775 uM) and 
(S,S)-22 (5.9 mM). 
FIG. 21A illustrates the structure of (S,S)-22-Cu'/L- 
amino acid ternary complex. 
FIG. 21B illustrates structural hypothesis to explain the 
observed stereoselectivity. Steric interactions between the 
dimethoxybenzyl groups and the amino acid R group desta 
bilize the (S,S)-22-Cu'/L-amino acid ternary complex. 
FIG. 21C illustrates structural hypothesis to explain the 














dimethoxybenzyl groups and the amino acid R group desta 
bilize the (S,S)-22-Cu'/L-amino acid ternary complex. 
FIG. 22A illustrates UV-vis spectral modulations for the 
addition of (S,S)-22-Cu' to a solution of PV (44 OM) in a 
1:1 MeOH:HO 50 mM HEPES buffer, pH=7.0. 
FIG. 22B illustrates association isotherms at 444 nm and 
654 nm for the addition of (S,S)-22-Cu' to a solution of PV 
(44 uM) in a 1:1 MeOH:HO 50 mM HEPES buffer, 
pH=7.0. 
FIG. 23A illustrates a displacement isotherm at 653 nm 
for the addition of D and L tryptophan into a solution of PV 
(44 uM) and (S,S)-22-Cu' (380 uM). Displacement titra 
tions performed in 1:1 MeOH:HO 50 mM HEPES buffer, 
pH=7.0. 
FIG. 23B illustrates a displacement isotherm at 653 nm 
for the addition of D and Lleucine to a solution of PV (44 
uM), (S,S)-22-Cu (380 uM). 
FIG. 23C illustrates a displacement isotherm at 653 nm 
for the addition of D and L phenylalanine to a solution of PV 
(44 uM), (S,S)-22-Cu' (383 uM). 
FIG. 24 illustrates the visible color of indicator-displace 
ment assays according to the teaching of the present inven 
tion. 
DETAILED DESCRIPTION 
Using assays of the present invention, the ee of an analyte 
may be determined by visible absorption changes. More 
specifically, a chiral receptor that differentially binds each 
enantiomer of an organic molecule may be used. An indi 
cator may be added that also binds the receptor, but is 
displaced by the analyte. The degree of displacement of the 
indicator from the receptor differs for each enantiomer of the 
analyte. Thus, the relative amount of each enantiomer may 
be determined by measuring either the amount of receptor 
bound indicator or the amount of free indicator. 
In some embodiments, color differences may be observed 
by the naked eye in order to ascertain an appropriate amount 
of enantiomeric excess. Such assays may be useful where it 
is desirable to use lower level technicians, where rapid 
determinations are needed, or where it is desirable to limit 
laboratory equipment expenses. For example, such assay 
may be useful in drug manufacturing quality control. 
In some embodiments, the assay may result in a color 
change that allows simple visual determination of enantio 
meric excess. Such embodiments may be particularly useful 
in drug manufacturing quality control and obtaining FDA 
approval of a drug. 
In some embodiments, enantiomeric excess may be mea 
Sured spectroscopically to determine actual excess more 
precisely. Direct measurements may be used in further 
mathematical calculations. These mathematical calculations 
may allow direct correlation of absorbance to ee. 
In some embodiments, enantiomeric excess may be mea 
Sured by nuclear magnetic resonance imaging. 
In a specific embodiment, concentration and ee may be 
determined in the same assay by a two-step analysis utilizing 
an achiral receptor and a chiral receptor in sequential indi 
cator-displacement assays. Alternatively, concentration and 
ee may be determined in one measurement using a two 
chambered cuvette having a chiral receptor and indicator in 
one chamber and an achiral receptor and a different indicator 
in the other chamber. The absorbance of the cuvette is 
measured at a wavelength corresponding to the isosbestic 
point of the solutions. 
The invention additionally includes the use of ee deter 
mination methods in high throughput screening of catalysts 
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and in the analysis of drugs or drug-producing chemical 
reactions during research or manufacture. During drug 
manufacture or manufacture of other enantiomerically 
biased compositions, assays of the present invention may be 
used to measure ee in a precursor rather than the final 
product 
In an exemplary embodiment empirical ee calibration 
curves may not be required for different analyte concentra 
tions. Since the requirement for different calibration curves 
is a serious limitation of present methods, the methods of the 
invention advantageously may provide a simpler, faster, and 
cheaper way to determine ee. 
The invention additionally includes the use of ee deter 
mination methods in high throughput screening of catalysts 
and in the analysis of drugs or drug-producing chemical 
reactions during research or manufacture. In the context of 
drug screening, assays of the present invention may be used 
to reduce the screening time of drugs, reduce the cost of drug 
development, expedite steps in the FDA approval process, 
and reduce human errors in drug screening. 
According to Some embodiments of the invention, indi 
cator displacement and enantioselective indicator-displace 





AAbs or F/F, f(GI) 
Enantioselective Indicator-Displacement Assay: 
H*:I+GH:G+I 
wherein 
AAbs or F/F f(G), ee) 
H-Host/Receptor; H Chiral host/receptor; I—Indicator; 
G, G, Gs Guest/Analyte; AAbs—Absorbance change; 
F—fluorescence intensity; F fluorescence intensity of an 
unbound indicator, a constant; G Total guest concentra 
tion; ee-Enantiomeric excess. In the enantioselective indi 
cator-displacement assay, two enantiomers (G and G) in a 
chiral sample are competing for a fixed amount of receptor/ 
indicator complex (H:I). 
In an exemplary embodiment, the present invention 
exploits the binding of boronic acids to C-hydroxyacids and 
catechols in aqueous media. For example, the affinity 
between Compound 1 and phenylactic acid (PL) (FIG. 1) 
was determined to be 1.3x10 M' (Table 1) using an 
indicator-displacement assay with the catechol-containing 
indicators pyrocatechol violet (PV) and alizarin complexone 
(AC)(FIG. 1). As expected, the achiral receptor Compound 
1 (FIG. 1) bound both enantiomers of PL with identical 
affinities (FIG. 3). Therefore, the total concentration of an 
unknown PL sample may be determined through an indica 
tor-displacement assay using Compound 1. 
The general reaction used to determine ee and concen 
tration in some embodiments may be as shown in FIG. 2. By 
incorporating chirality into the receptor structure, the dis 
placement of the indicator by chiral analytes is enantiose 
lective. This has been confirmed by the binding of chiral 
receptors (Compounds 2 & 3). D/L-PL was studied using an 
indicator-displacement assay also. All of these receptors 
showed comparable affinities (Table 1) to C-hydroxyacids 
used and PV or AC. Compound (S,S)-2 showed 2.8 times 
larger affinity to L-PL over D-PL (FIG. 3), while compound 














pound (S)-3, which has one less stereogenic center, dis 
played less discriminating power between D/L-PL. The 
association between (S,S)-2 and other C-hydroxyacids were 
also studied (Table 2) and samples with R-configurations 
were generally favored (with the exception of lactic acid 
(LC)). 
TABLE 1. 
Association constants (K1/10 M') of boronic receptors 
(Compounds 1-3) with indicators (PV, AC) 
and D/L-phenylactic acids (PL)." 
1 (S,S)-2 (R,R)-2 (S)-3 
PV 2.3 13 11 15 
AC 13 63 61 57 
D-PL 1.3 3.4 8.3 1.8 
L-PL 1.3 9.6 3.3 2.5 
"Measured by competitive spectrophotometry in 75% (v/v) methanolic 
aqueous solution buffered with 10 mM HEPES at pH 7.4 (default buffer), 
data with PV or AC were taken at 520 nm and 536 nm respectively. 
TABLE 2 
Association constants (KR Ks) between Compound 
S.S)-2 and C-hydroxyacid substrates." 
PL MD HI HB LC HM 
K/(10M) 3.4 2.0 4.2 3.2 4.5 4.3 
Ks/(10M) 9.6 3.0 5.9 42 4.3 5.5 
"Measured as stated in Table 1. KR and Ks are association constants for R 
and S-configured C-hydroxyacids respectively. 
When monitoring the absorbance (520 nm) of the recep 
tor-indicator complex, the different displacement profiles by 
D/L-PL dictate that at a given concentration, the enantio 
meric samples have distinct UV absorbances. The difference 
(AAA) can be as large as 0.27. An A vs. ee correlation at 1.5 
mM analyte concentration was determined (FIG. 4). The 
absorbance of the sample increased (filled black diamond) 
when the percentage of stronger binding enantiomer (L-PL) 
was decreased because of less competitive binding. When 
the total analyte concentration was adjusted to 3.0 mM, the 
overall absorption of this series of samples (blue diamond) 
decreased due to more efficient displacement of the indica 
tor; while the relative correlation between Aandee remained 
unchanged. When receptor Compound (S,S)-2 was replaced 
by its enantiomer Compound.(R,R)-2 at a slightly different 
concentration, a near-mirror image A-ee correlation (red) 
was observed. The A-ee relationships were found to be 
curved (FIG. 4) where the change in absorbance was 
slightly, but consistently greater. This likely occurs because 
the stronger binding enantiomer is more dominant in the 
overall signal modulation. Because the behavior of all the 
species obey solution equilibria, the absorbance change 
through the variation of Solution composition may be math 
ematically modeled. 
In one mathematical model, four interacting Substances 
(indicator I, chiral receptor H, two enantiomers of the 
anyalyte G/Gs) are present in Solution. Their solution 
species concentrations are interdependent through three 
equilibria: HG=KGH), HG=KGH), and HI 
=KIH). These concentrations are related by three mass 
balances: I+HI–I, G+Gs+HG+HGs=G, and 
H+HI+HG+HG=H. The absorbance of the sample 
is given by Beer's Law (Eq. 1), 
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and ee is defined in the terms of analyte concentrations (Eq. 
2). 
(GR +HGRI) - (Gs) - HGs) 
G, 
(Eq. 2) 
ee R = 
The total of eight equations are mathematically transformed 
to produce Eq 3. 
A -ebi, 
bAe 
eibi, - A 
-- -- 
K (A - elibi) 
(Eq. 3) 
KRG, (1 + eeR)(eibi - A) 
-- 
2A(K - KR) - bi (el K - e KR) 
KSG, (1 - eeR)(eibi - A) 
2A(K- Ks)-bi,(eu Ki-ei Ks) 
Parameters e. e. and K are determined from a receptor/ 
indicator isotherm, K and Ks from an indicator-displace 
ment assay, I, and H, are gravimetrically determined, and the 
analyte total concentration G, is obtained from an indicator 
displacement assay with achiral receptor Compound 1 as 
previously described. Therefore, there are only two vari 
ables—A and ee- in Eq. 3. Eq.3 may be further mathemati 
cally transformed into the standard polynomial format PA+ 
QA+RA+SA+T-0 with the aid of the commercial 
software Mathematica R, where P, Q, R. S. T are all func 
tions of ee. Therefore, by solving the 4" order polynomial 
equation, the absorbance of the displacement cocktail is 
successfully correlated to the ee of the analyte. The eight 
experimentally determined constants (e., et, K. K. Ks, I 
H, and G) are input into Eq. 3 to generate theoretical data. 
When applied to the O.-hydroxyacid embodiment described 
above, theoretical data (open diamonds in FIG. 3) correlates 
well with the actual observations. 
The indicator-displacement embodiment described above 
may be used to determine the concentration and ee of an 
C-hydroxyacid sample by carrying out two independent 
measurements. First, the absorbance spectrum from an indi 
cator-displacement assay containing the achiral receptor 
(Compound 1) and PV may be measured to obtain the 
overall concentration of the C-hydroxyacid. Second, another 
absorbance reading with a chiral ensemble (Compound 
(S,S)-2 and PV) may be used in Eq. 3 to quantify the ee of 
the sample. This may be performed without generating an 
empirical ee calibration curve for the determined analyte 
concentration. The effectiveness of this assay is shown in 
Table 3, where the total concentration and ee of three PL 
samples were determined." The accuracy of the overall 
concentration was it 10% whereas the ee could be deter 
mined within +20% error. 
TABLE 3 
Determination of concentration and ee of 
unknown phenylactic acid (PL) samples. 
Concentration Concentration 
(Actual) mM (Determined), mM ee (Actual) ee (Determined) 
1 2O.O 21.5 1.OO O.98 
2 26.5 28.1 -O.89 -O.71 














Aromatic boronic acids interact strongly with bifunctional 
Substrates Such as Sugars, diols, and a-hydroxycarboxylates 
in aqueous media. A few boronic acid-based receptors show 
enantioselectivities. For example, fluorescent Sugar sensor 
(8) differentiates D-from L monosaccharides. Compounds 9 
and (+)-10 were developed to diastereomerically derivatize 
chiral diols, such that their ees could be determined by 
proton (H) NMR. Exemplary embodiments of enantiose 
lective indicator-displacement assays may be based on the 
reversible covalent interactions in aqueous media between 
aromatic boronic acids and O-hydrocarboxylates or vicinal 
diols. More specifically, an enantioselective indicator-dis 
placement assay based on a chiral boronic acid receptor and 
a colorimetric indicator pyrocatechol violet (PV) may be 
used to determine the ees of C-hydroxycarboxylate samples. 
The concentration of a sample, which is needed for its ee 
determination, may be measured with an achiral displace 
ment assay prior to the ee analysis. Examples 8-12 demon 
strate a two-measurement protocol (Scheme 1), in which the 
ee values of three phenylactic acid (PL) samples were 
determined with 15-20% error. In addition, according to the 
present invention, the sensitivity of the assay can be tuned 
by changing the indicators and other Substrates can be 
analyzed with this assay. Thus, the present invention pro 
vides experimental protocols that improve the accuracy of ee 
determination. 
Due to their biological significance, C.-amino acids have 
been widely studied from the perspective of enantioselective 
recognition. Despite this, there exist very few ee sensors for 
free amino acids. According to some non-limiting embodi 
ments of the present invention, Indicator Displacement 
Analyses (IDA) may be directed to amino acid detection by 
using metal coordination as the primary associative interac 
tion. This approach takes advantage of the large absorbance 
shifts afforded when indicators such as pyrocatechol violet 
(PV) coordinate metal ions, as well as the structural orga 
nization of cyclic C-amino acid-metal ion chelates. The 
coordinatively unsaturated trans-diaminocyclohexane 
(DACH) derived Cu' complex (S,S)-22-Cu' (FIG. 21A) 
was designed as a host complex. This species is envisioned 
to be capable of associating with both the indicator PV and 
amino acid guests in a bidentate fashion. Further, (S,S)-22 
Cu" presents the Cu' center in a chiral C, symmetric 
environment to selectively accommodate one amino acid 
enantiomer. The ligand (S,S)-22 is prepared from commer 
cially available materials via a one-step reductive amination 
procedure (see Example 13). 
Control of the multiple coordinative equilibria involved in 
the IDA necessitates consideration of the relative abilities of 
the species involved to act as ligands for Cu". Enantiose 
lectivity is expected to arise from diastereomeric interac 
tions within a host/guest complex. In light of the ability of 
C-amino acids to form stable 2:1 complexes with Cu", it is 
desirable that (S,S)-22-Cu" be robust enough to retain the 
Cu center in the presence of several equivalents of amino 
acid. The formation constant (logK (M)) for DACH:Cu' 
has been reported as 10.9 in aqueous solution, which is two 
orders of magnitude greater than the formation constants of 
Cu' complexes of hydrophobic amino acids under similar 
conditions. Although the formation constant of 22-Cu" is 
likely lower than that of DACH:Cu' because the vicinal 
amines are secondary, ternary amino acid complexes of 
22-Cu' are expected to be relevant when the guest is not in 
great excess. Coincidentally, the formation constant of Cu'. 
PV has been reported as 10.9, implying that the indicator has 
an affinity for Cu' comparable to that of 22 and of amino 
acid guests. 
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Titration of (S,S)-22-Cu' into a buffered 1:1 MeOH:HO 
solution of PV resulted in an increase in absorbance at 653 
nm accompanied by a decrease in absorbance at 445 nm, 
giving the vivid color change from pale yellow to intense 
blue that is characteristic of PV coordination to a metalion. 
The host/indicator association isotherm exhibits sharp Satu 
ration near 1 equivalent of (S,S)-22-Cu', suggesting the 
formation of a stable (S,S)-1-Cu':PV complex (see Example 
13). 
Addition of C-amino acids to a solution of (S,S)-22-Cu' 
and PV resulted in displacement of PV from the Cu' center, 
giving a shift from the blue color of Cu'-bound PV to the 
yellow of free PV. Of the five amino acids assayed (alanine 
(Ala), Valine (Val), leucine (Leu), tryptophan (Typ) and 
phenylalanine (Phe)), all but Ala produced an enantioselec 
tive response, with the D-enantiomer displacing PV most 
effectively. It was found that the enantioselective response 
was contingent upon the host:indicator ratio and that roughly 
a seven-fold excess of (S,S)-22-Cu' over PV was optimal. 
Under the same conditions, the enantiomer of the host 
complex, (R,R)-22-Cu' was found to prefer L-amino acids 
to a similar degree that (S,S)-22-Cu' favors D-amino acids. 
The enantiomeric discrimination is nearly identical for Val, 
Leu, Typ and Phe, but the aromatic side chain containing 
amino acids displaced PV more effectively than those con 
taining aliphatic side chains, which could result from an 
attractive JC-T interaction in a ternary complex. Representa 
tive spectral modulations and displacement isotherm at 653 
nm for Val are shown in FIGS. 19A and 19B respectively. 
The displacement isotherms do not conform to the theo 
retical indicator displacement model, indicating that a more 
complex process is operative. Given the large affinity of 
C.-amino acids for Cu', it is likely that (S,S)-1, as well as PV. 
is displaced toward the end of the titration when the amino 
acid is in large excess. While this deviation from standard 
IDA model behavior prohibits the estimation of host-guest 
formation constants, the enantioselective response of the 
sensing ensemble can Successfully be used for ee determi 
nation. 
Relationships between amino acid ee and absorbance 
were obtained at constant amino acid concentration under 
conditions that accentuated absorbance differences between 
enantiomers. The absorbance was monitored at 645 nm, so 
that the weaker binding L-enantiomer produced a larger 
absorbance. To optimize the sensitivity of the assay, the 
amino acid concentration that gave the greatest absorbance 
difference between the enantiomers was identified from the 
enantiomeric displacement isotherms (FIG. 19B). At that 
point, the concentrations of all species were increased (keep 
ing relative concentrations constant) thus increasing the 
absorbance values produced by both enantiomers. By 
enhancing both signals in this way, the difference between 
the absorbance values caused by each enantiomer is ampli 
fied, thus augmenting the sensitivity. 
In FIG. 19B, the greatest difference between the D and L 
isotherms is achieved at about 4.6 eq Val (relative to 
(S,S)-22-Cu'), where the total absorbance values are still 
quite large and the signals cannot be increased significantly 
within the upper limit of the validity of Beer's Law (the 
absorbance caused by L-Val is 0.85). It was found that by 
increasing the concentration of (S,S)-22 in the ensemble, the 
greatest enantioselectivity is observed later in the titration 
(FIG. 19C), which is likely due to a more competitive 
displacement process. In FIG. 19C, significant enantiose 
lectivity is observed at 12 eq Val, where L-Val elicits an 
absorbance response of 0.58. The concentrations of all 













(1/0.58) to generate an ee curve with an absorbance maxi 
mum (at 100% L-Val) near 1.0. By adjusting the concentra 
tions of the ensemble in this manner, the absorbance differ 
ence between enantiomers was roughly doubled relative to 
the initial conditions. 
The ee curves presented in FIG. 20 are remarkably linear 
(R->0.99), and in all cases span an absorbance range greater 
than 0.2 absorbance units, demonstrating the ensemble to be 
useful over the entire ee range. FIG. 20A shows that ee 
curves for Leugenerated with (S,S)-22-Cu" and (R,R)-22 
Cu" at identical concentrations exhibit a mirror image rela 
tionship, as required by the principles of Stereochemistry. 
Decreasing the total concentration of amino acid at which 
the ee curve is generated gives a larger overall absorbance 
at 645 nm, as shown for Typ (FIG. 20D). At a lower amino 
acid concentration, the amino acid competes with PV for 
(S,S)-22-Cu less effectively, and so a higher fraction of the 
indicator is bound to the host, giving a larger absorbance. 
The calibration curves were used to analyze the ees of 
various amino acid samples. By UV-vis measurement 
samples of unknown ee were determined with an average 
error of 12%, as reported in Table 4. 
TABLE 4 
Enantiomeric excess determinations of amino 
acid samples by UV-vis method. 
Amino Acid Sample ee (Actual) ee (Determined) 
valine 
A. -50% -54% 
B 25% 12% 
C -65% -88% 
phenylalanine 
D 67% 81% 
E -82% -78% 
F SO% 57% 
tryptophan 
G 90% 92% 
H 33% S8% 
I -71% -56% 
The enantioselectivity of this IDA arises from in a mixed 
ligand Cu' complex involving 22 and the amino acid guest. 
The preference for D-amino acids exhibited by (S,S)-22 
Cu" is rationalized by the following analysis. The 
dimethoxybenzyl groups of 22-Cu' are expected to orient as 
shown in FIG. 21 to avoid A'-strain with the cyclohexane 
ring, creating a C. symmetric cavity in which the Cu" 
resides. Assuming a square planer Cu" geometry, chelation 
of a D-amino acid allows the R group to avoid steric 
interactions with the dimethoxybenzyl groups that the bound 
L-enantiomer cannot evade. This structural arrangement is 
expected to stabilize the D-complex over the L-complex, 
and give rise to the more effective indicator displacement 
observed with (S,S)-22-Cu' for D-amino acids. 
Thus, the present invention provides an enantioselective 
IDA for amino acids. The sensing ensemble allows for the 
measurement of non-derivatized amino acid ees by a simple 
technique (UV-vis spectrophotometry) and requires trivial 
synthesis. More broadly, the methods and compositions of 
the present invention provides enantioselective IDAs that 
may be useful for rapid and simple means of ee determina 
tion for a variety of substrates. 
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EXAMPLES 
The following examples are included to demonstrate 
specific embodiments of the invention. It should be appre 
ciated by those of skill in the art that the techniques 
disclosed in the examples that follow represent techniques 
discovered by the inventors to function well in the practice 
of the invention. However, those of skill in the art should, in 
light of the present disclosure, appreciate that many changes 
can be made in the specific embodiments that are disclosed 
and still obtain a like or similar result without departing from 
the spirit and scope of the invention. 
Example 1 
General Methods 
'Hand 'C NMR spectra were recorded on a Varian Unity 
Plus 300 spectrometer. UV-vis measurements were per 
formed on a Beckman DU-70 UV-vis spectrometer. Low 
resolution and high-resolution mass spectra were measured 
with Finnigan TSQ70 and VG Analytical ZAB2-E instru 
ments, respectively. Reagents were used as purchased from 
various commercial Sources. 
Example 2 
General Procedures for Syntheses of Boronic 
Receptors (Compounds 1-3) 
A). 2-Formylbenzeneboronic acid (1 mmol) was dis 
solved in anhydrous CH-OH (2.5 mL) under argon protec 
tion. Substituted pyrrolidine (1 mmol) was added dropwise 
to the solution which was stirred for 16 hr before NaBH 
(0.75 mmol) was added slowly. The solution was stirred at 
rt. for 1 hr, followed by addition of another batch NaBH 
(0.75 mmol). One hr later, the solvent was removed under 
vacuum and the residue was diluted with CHCl (25 mL). 
The white precipitate was removed with vacuum filtration, 
with the filtrate subsequently concentrated. The residue was 
either chromatographed on neutral alumina column (0-4% 
CH-OH in CHCl), or precipitated from a CHCl solution 
through addition of hexanes to yield the pure product. 
B). 2-Formylbenzeneboronic acid (1.57 mmol) was dis 
Solved in anhydrous dichloroethane (6.3 mL) under argon 
protection. After the slow addition of (R,R)- or (S,S)-2,5- 
bis(methoxymethyl)-pyrrolidine (1.57 mmol), the solution 
was stirred at r.t. for 16 hr. AcOH (1.57 mmol) was added 
followed by NaBH(OAc) (2.36 mmol) and the solution was 
stirred for a further 6 hr. Solvent was removed under vacuum 
and the residue was diluted with CHCl (25 mL) before the 
precipitate was removed with vacuum filtration. The filtrate 
was concentrated and the residue was Subjected to neutral 
alumina chromatography (0-2% CH-OH in CHCl) to 
afford the pure product. 
Compound 1. "H NMR (300 MHz, CDOD) & 7.57 (d. 
J=6.7 Hz, 1H), 7.20 (m,3H), 4.13 (s. 2H), 3.10 (m, 4H), 2.06 
(m, 4H); HRMS (CI): calcd. (M+H) 206.1352, (3M-3H2O+ 
H) 562.3584, found 206.1347, 562.3606. MS (CI): calcd. 
(3M-3H2O+H)" 562.3, found 562.0. 
Compound (S,S)-2. "H NMR (300 MHz, CDC1+1 drop 
CDOD) & 7.83 (m. 1H), 7.25 (m, 3H), 4.10 (d. J=13.1 Hz, 
1H), 3.87 (d. J=12.8 Hz, 1H), 3.31 (d. J=5.1 Hz, 4H), 3.23 
(s, 6H), 3.19 (m, 2H), 2.02 (m, 2H), 1.70 (m, 2H); C NMR 
(75.5 MHz, CDC1+1 drop CDOD) & 142.5, 136.3, 130.3, 













(M+H)" 294.1877, found 294.1875. MS (CI): calcd (M+H)" 
2.94.2, (3M-3HO+H)"862.6, found 294.0, 827.0. 
Compound (R,R)-2. "H NMR (300 MHz, CDC1+1 drop 
CDOD) & 7.84 (m. 1H), 7.29 (m. 2H), 7.23 (m. 1H), 4.11 
(d. J=12.8 Hz, 1H), 3.88 (d. J=13.1 Hz, 1H), 3.33 (d.J=5.1 
Hz, 4H), 3.24 (s, 6H), 3.20 (m, 2H), 2.03 (m, 2H), 1.72 (m, 
2H); HRMS (CI): calcd. (M+H)" 294.1877, found 294.1884. 
MS (CI): calcd (M+H)' 294.2, (3M-3HO+H) * 862.6, 
found 294.0, 826.7. 
(S)-3. "H NMR (300 MHz, CDC1+1 drop CDOD) & 
7.84 (m. 1H), 7.29 (m, 2H), 7.17 (m, 1H), 4.18 (d. J=12.3 
HZ, 1H), 3.48 (d. J=12.3 Hz, 1H), 3.40 (dd, J=5.6.95 Hz, 
1H), 3.29 (dd, J=5.6, 9.7 Hz, 1H), 3.28 (s.3H), 2.81 (m, 2H), 
2.29 (m. 1H), 2.01 (m. 1H), 1.73 (m, 3H); 'C NMR (75.5 
MHz, CDC1+1 drop CDOD) & 142.6, 136.1, 130.12, 
130.07, 127.4, 75.2, 63.7, 62.2, 59.1, 54.1, 28.6, 22.8; 
HRMS (CI): calcd. (M-OH) 232.1509, (3M-3HO+H)" 
694.4370, found 232.1517, 694.4404. 
Example 3 
Derivation of Eq. 3 





Host & Guest Mass Balances: 
(GR +HGRI) - (Gs) + HGs) 
G, 
(8) 
ee R = 
From (1) and (2) 
(9) eHibi - A 
= 
bAe 
A - eibi, (10) 
HI) = bAe 
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From (9), (10) and (5) 
-continued 
KSG, (1 - eeR)(eibi - A) (17) 
HI ebi - A (11) (sl2AKK) bicek, -ek) 
KI K(A -ebi) 5 
From (7) and (8) The A vs. ee relationship is: 
Define X=G+HG), Y=G+HGs) 10 
A -ebi, eibi, - A KRG, (1 + eeR)(eibi - A) 
X+Y=G, bAe "KA-embl.) 2A(K- Key-blen K, -e K)" 
Then Ks G. (1 - eeR)(eibi - A) = H, 
2A(K - KS) - bi (eH1 K-8 Ks) 
X-Y-Gee. 15 
e, e, K. From 1:1 Host/Indicator Isotherm 
(12) K. K. From Displacement Assay G, 
X = GR - HGR = (1 + eeR) 
2 I, H. G. Gravimetric 
G, (13) 20 
Y = (Gs)+(HGs) = (1 -eer) Example 4 
Determination of Association Constants Between 
HGF=KIGIIHF (3) Receptors and Indicators (K) 
25 
A solution of PV (149 uM) and Compound 1 (2.22 mM) 
(12) was titrated into a UV cuvette containing a solution of PV 
(149 uM) at r.t. (FIG. 5A). The absorbance change (AA) was 
so plotted against the increasing total concentration of Com 
pound 1 at 520 nm (FIG. 5B). The association constant (K) 
G, 
GR +HGR = (1 + eeR) 
(3) and (12) give: was determined through least squares regression curve 
fitting of the data at 520 nm with the 1:1 binding isotherm 
equation. 
(1 + eeR)GHKR (14) HGR = 35 
2(1 + HKR) Example 5 
GP = (1 + eeR)G, (15) 
GR = 2(1 + HKR) Determination of Association Constants Between 
Receptors and C-hydroxyacids (K. Ks) 
40 
(11) and (14) give: A solution of PV (149 uM), Compound (S,S)-2 (0.510 
mM) and D-PL (30.0 mM) was titrated into a UV cuvette 
containing a solution of PV (149 uM) and Compound 
HGR = as "En (16) as (S,S)-2 (0.51 mM) at rt. The absorbance at 520 nm was 
y RJ tit H spy R recorded after at least 1 min to allow the system reaching 
Likewise, equilibrium (FIG. 6A). The absorbance change (AA) was 
(1 - eeR)G,HKs (17) plotted against the ratio of D-PL concentration over Com 
HGs = 21. HK) pound (S,S)-2 concentration (FIG. 3). The association con 
50 stant (K) was determined with the competitive binding 
KSG (1 - eer (eibl, - A) method with the data at 520 nm (FIG. 6B). (See also FIG. 
2A(K - KS) - bi (eli K-8 Ks) 7.) 
Example 6 
From (7), (10), (11), (16) and (17): 55 
HI+/HII+IHGF-IHGs =H, (7) Determination of A ee Correlation 
Two ensemble solutions were prepared with PV (149 
A - eibi, (10) 60 uM), Compound (S,S)-2 (0.510 mM) and either D- (solution 
(HI) = - A A) or L-PL (solution B) at 3.00 mM. Solution A was 
incrementally titrated into B until ee reached 0, while the HI sib - A (11) 
H = : - UV-vis spectrum was recorded after at least 3 minto allow Ki Ki (A -&Hibi) the system reaching equilibrium. (FIG. 8A). The titration 
KRG, (1 + eeR)(eibi - A) (16) 65 was repeated with Badding into A to complete the ee range 
2A(K - KR) - bi (el K - & KR) from -1 to 1. Absorbance change was plotted against ee at 
520 nm (FIG. 8B). 
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Example 7 
Determination of the Concentration and ee of an 
Unknown PL Sample 
A PL sample of unknown concentration and ee in the 
default buffer (0.5 mL) was added in a 5.0 mL volumetric 
flask containing PV (149 uM) and Compound 1 (0.575 mM). 
The absorbance at 520 nm was recorded after at least 3 min 
to allow the system to reach equilibrium. The overall con 
centration was extracted from calibration curves of A vs. PL 
concentration (FIG.9) at 520 nm. The same sample (0.5 mL) 
was added in another solution containing PV (149 uM) and 
Compound (S,S)-2 and diluted to 5.0 mL. The absorbance at 15 
520 nm was recorded after at least 3 min and input into Eq. 
3. The polynomial equation was solved in MathematicaR) to 
afford the ee of the sample. 
10 
Although only exemplary embodiments of the invention 
are specifically described above, it will be appreciated that 
modifications and variations of these examples are possible 
without departing from the spirit and intended scope of the 
invention. 
25 Example 8 
Design of Enantioselective Receptors 
In many reported boronic acid receptors (e.g. compound 30 
8), neighboring tertiary amino groups were installed in 
proximity of boron atoms. Such amino groups were postu 
lated to accelerate the association equilibria with their 
Substrates, by serving as proton shufflers, or by modulating 
the thermodynamics of the association as Lewis bases for 
the boron atoms. It was expected that the nitrogen atom 
coordinates with the electron-deficient boronatom to form a 
relatively rigid 5-member-ring structure, as drawn for com 
pound 8 in FIG. 10. Notwithstanding recent debate about the 
strength of the BN interaction, and whether the bond 
remains intact in protic media, it was postulated that if 
stereogenic centers were installed in the vicinity of the 
postulated B N bond in the receptor, the stereocenters 
would impart enantioselectivity to the association between as 
the receptor and enantiomeric Substrates. Hence, the chiral 
receptors 15-21 were devised and synthesized. 
35 
40 
Scheme 2. Synthesis of 2-methylpyrrolidinyl phenylbo 














HN AcOH. r.t. 









Synthesis. Boronic acid receptors 11-21 were prepared 
through reductive amination between o-formyl arylboronic 
acids and various pyrrolidine-based secondary amines 
(Scheme 2). For the secondary amines without C.-substitu 
ents, such as pyrrolidine or piperidine, the reductive ami 
nation was carried out smoothly with Schiff base formation 
in methanol followed by reduction with NaBH. When 
C-Substituted secondary amines were used, the reduction 
was performed with NaBH(OAc) to ensure a selective 
reduction of the iminium ions. The products were purified 
with alumina chromatography with satisfying yields (usu 
ally more than 70%). 
Example 9 
Fluorescence Indicators 
The foregoing examples described the enantioselective 
associations between receptor (S,S)-15 and various C-hy 
droxycarboxylates. With PV serving as a calorimetric indi 
cator (FIG. 11), the assay was successfully applied in 
simultaneous determination of concentrations and ees of 
unknown PL samples. In those measurements, the deter 
mined ees had an average of 15% error from the actual 
values. The main objective of this study was to optimize the 
protocols to improve both the accuracy and sensitivity of the 
assay. 
In order to devise assays with higher sensitivities and 
improved accuracy, fluorescent indicators were examined. 
The indicator 4-methylesculetin (ML, FIG. 11) was found to 
undergo a large fluorescence intensity enhancement upon 
binding with boronic acid receptors such as 13 and (S,S)-15. 
At pH 7.4 in a 75%/25% methanol/HO solution, the emis 
sion of ML was largely suppressed by the photo-induced 
electron transfer (PET) process from the hydroxyl groups to 
the coumarin moiety. Therefore, the free ML showed rela 
tively weak fluorescence. Upon binding with boronic acid 
receptors, the electron deficient boron atoms raised the 
oxidation potential of the hydroxyl groups on ML, so that 
the presumptive PET process was thermodynamically dis 
favored. Thus, when binding with compound 13, the fluo 
rescence from the coumarin moiety in the complex had at 
least a 10-fold enhancement over the free indicator (FIGS. 
13A and 13B). Upon addition of PL, the fluorescence 
intensity decreased due to the competitive binding of PL to 
the receptors that released the indicator into solution (FIG. 
13C). The association constants between the receptors and 
ML were determined through the 1:1 binding isotherms 
(FIG. 13B, see supporting information). The affinities of the 
receptors to PL were determined with a traditional competi 
tive spectrophotometric method (FIG. 13D). The affinity 
data are listed in Table 5. 
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TABLE 5 
Association constants (K/10M) of boronic receptors 
13. (S,S)-15) with indicator ML and DLPL" 
ML D-PL L-PL 
13 24.92 + 0.07 4.50 + 0.09 (4.38 + 0.05) 4.56 + 0.08 
(4.39 + 0.06) 
(S,S)-15 30.19 + 1.55 4.35 + 0.07 (4.27 + 0.24) 10.86 + 0.03 
(10.45 + 0.10) 
Measured via 1:1 binding isotherms or a competitive fluorimetric method 
in the default buffer (FIG. 3, footnote). Association constants obtained 
from iterative curve fitting are shown in the parentheses for comparison. 
The fluorescence displacement profiles of PL with the 
achiral (13) and chiral ((S,S)-15) receptors are shown in 
FIG. 14A. As expected, with chiral receptor (S,S)-15, the 
stronger associating PL enantiomer (LPL) resulted in a more 
effective fluorescence quenching event than D-PL: while 
their fluorescence displacement profiles were virtually iden 
tical with achiral receptor 13. The ee-dependent fluores 
cence quenching (of an indicator-receptor ensemble) profiles 
of PL at two different total substrate concentrations are 
displayed in FIG. 14B. The profile derived from the larger 
total concentration of the guest (1.2 mM, blue) showed an 
overall more effective fluorescence quenching with an oth 
erwise similar shape. The fluorescence intensities were 
growing with the increasing ee of the weaker associating 
enantiomer D-PL. The slope of the emission intensity as a 
function of ee (dE/dee) was greater when the ee of D-PL 
became larger (FIG. 14B), because the concentration change 
of the stronger associating enantiomer (ADL-PL) had a more 
pronounced effect in modulating fluorescence intensity 
when its concentration (IL-PL) was relatively small than 
Vice versa. Through this study, an enantioselective indicator 
displacement assay for PL was established based upon 
enantioselective associations between receptor (S,S)-15 and 
D/L-PL, and the utilization of the fluorescent indicator ML. 
Example 10 
Mathematical Analysis of Solution Equilibria 
Because the enantioselective fluorescent indicator dis 
placement assay follows solution equilibria (Scheme 1), a 
relationship between the ee of a sample and the fluorescence 
intensity can be established. One goal was to discover if 
iterative curve fitting of the F/F. vs. ee curve would give a 
more accurate ee assay than previously reported. 
The fluorescence intensity F is related to both the free and 
bound indicator I and HI via eq. 1 (I the intensity of the 
excitation source; p—fluorescence quantum yield; e—molar 
absorptivity at the excitation wavelength; b path length) 
.58 With F, defined as the fluorescence intensity from the 
free indicator (FEkbl), eq. 10-1 is converted to eq. 10-2. 
When a mixture of enantiomeric guests is present, the 
concentrations of all the solution species are defined by three 
solution equilibria equations 10-3 to 10-5. Other restricting 
factors include mass balances for the receptor (H), the 
indicator (I), and the analyte (G, Gs), as well as the 
definition of ee (eq. 10-6 to 10-9). By rearranging the 
equations with the aid of the commercial software Math 
ematica,59 the concentrations of all the solution species (I. 
HI, IHG, G, HGs), Gs, and HI) can be expressed 
as functions of measurable parameters (HI, II, GI, KI. 
K, Ks, and n). When these symbolic expressions are 













is given in eq. 10-10. Other parameters can be independently 
determined through 1:1 binding isotherms (KI, n), competi 
tive binding methods (K. Ks), gravimetric measurements 
(HI, II), and achiral indicator-displacement assays (GI), 
respectively. If K equals Ks, as in a displacement assay 
with an achiral host, eq. 10-10 can be rearranged to give the 
typical equation for the competitive spectrophotometric 
method (see Supporting information). The correlation 
between the traditional approach and the present analysis 
provides validation for the F/F. vs. ee relationship shown in 
eq. 10-10. 




III+/HII= III, (7) 
IGF-IGSF-FFIGF-IHGs, GI, (8) 
(GR +HGRI) - (Gs) - HGs) (9) 
IGI, 
-- (F / F - 1) -- 
K(n - FAF) 
KRG, (1 + eer) (1 - F / F) -- 
2 (Ff Fi) (Ki - KR) - (nK - KR) 
KSGI, (1 - eer)(1 - F / F) 
2 (Ff F)(K - KS) - (nK - KS) 
ee R = 
(F / F - 1) II, 
in - 1 
(10) 
When all the measurable parameters (KI, n, K, Ks, HI, 
II, GI) were introduced into eq. 10-10, calibrating curves 
of F/F. vs. ee with given Gl, concentrations were generated. 
Although the calculations were very close, they did not 
always sufficiently reproduce the experimental data for a 
good ee determination. This is largely due to the fact that the 
parameters are necessarily determined under somewhat dif 
ferent conditions. Fluctuations in room temperature, the 
power supply of the fluorimeter, and the sensitivity of the 
detection system, etc., over the time when the measurements 
of the parameters were conducted contributed to the dis 
crepancy between the calculated and experimental F/F, vs. 
ee data. Therefore, a method enabling iterative data fitting of 
experimental F/F. vs. ee curves by adjusting K and Ks, with 
secondary consideration of other parameters was sought. 
Curve fitting of the 4” order polynomial F/F, f(ee) relation 
ship (eq. 10-10) presented a daunting task. Even traditional 
competitive binding curves without the ee consideration had 
not been previously fit iteratively. However, direct determi 
nation of binding constants from competitive binding curves 
through iterative data fitting may be feasible with the use of 
commercial software. 
As a start, the nonlinear function A=f(GI) in Scheme 1 
was studied without the ee consideration. The absorbance 
was correlated to indicator concentrations through Beer's 
Law (eq. 10-11). The II and HII values were dictated by 
solution equilibria between H, I and G (eqs. 10-12 and 
10-13), with restrictions from their mass totals (eqs 10-14 
10-16). By rearranging eqs 10-12 and 10-14, I and HI 
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were expressed as functions of H, and Subsequently these 
functions were introduced into the Beer's Law eq. 10-11 to 
afford eq. 10-17 in the form of A=f(HI). Similarly, HG 
was expressed as a function of H by rearranging eqS 10-13 
and 10-16. The symbolic values of HI and HG in terms 
of H were introduced into the mass balance of H, (eq. 
10-15) to afford a cubic equation in H (eq. 18). At this 
point, all the parameters in eqs 10-17 and 10-18, except for 
K that was to be determined, were known from gravimetric 
means (HI, II, GI) or previous measurements (e., e. 
K). 
Actual curve fitting was achieved by the nonlinear least 
squares curve fitting module of the commercial Software 
Origin, that ran a brief user-defined function compiled with 
the LabTalk computation language integrated in the Software 
package. The compiled function had a two-step iterative 
cycle. First, an arbitrarily estimated value was assigned to 
K. DH was Subsequently obtained from Solving the cubic 
eq. 10-18 based on the Newton-Raphson method. Because 
of the multiplicity of the roots from a cubic equation, it 
should be stressed that a judicious choice of the initial value 
of H (H for the Newton-Raphson method) is pivotal to 
the Success of obtaining a reasonable calculated value of 
H. Second, the obtained H was introduced to eq. 10-17 
to afford a calculated absorbance (A) value. This value was 
compared with the measured A value by the curve-fitting 
module to evaluate the quality of the initially assigned K. 
The program then generated a new, and usually Superior, 
value for K based upon the Levenberg-Marquardt algo 
rithm, and the above process was repeated until the best 











AFebIII (1+KFH)+ebKIHIFIFA (1+KFH) (10-17) 
The above algorithm can be applied generally in cases 
involving two interdependent equilibria. For indicator-dis 
placement studies, there are usually 6 parameters besides the 
Variables A and Gl-Ki, K, HI, II, e, and e, that can 
be adjused to obtain a satisfying curve fitting (i.e. R>0.99). 
The following procedure was established to restrict the 
variations of the parameters in order to afford a reasonable 
and reproducible K. H., II, which were obtained gravi 
metrically, and K, which was independently determined 
from a 1:1 binding isotherm, were treated as fixed param 
eters. The extinction coefficients e, and e, were dependent 
on experimental conditions (temperature, background 
absorption, etc.). Therefore, they were allowed for variation. 













with one example shown in FIG. 15A. Selected results are 
shown in parallel with association constants determined by 
the traditional competitive spectrophotometric method in 
Table 9. A similar approach was applied to data sets based 
on fluorescence measurements (one example in FIG. 15B), 
and the results are shown in Table 5. The fitting quality 
exemplified in FIG. 15, the accuracy displayed in Tables 5 
and 9, the generality to multiple equilibria problems, and the 
ease of operation, make this approach a preferred embodi 
ment of the invention. 
Next, the algorithm targeting iterative curve fitting of an 
A or F/F, f(ee) calibration curve in an enantioselective 
indicator-displacement assay was developed in a similar 
manner, but with one step of higher complexity (see Sup 
porting information). In an assay based upon fluorescence, 
there were 7 parameters besides variables F/F, and ee: K, n, 
K, Ks, II, HI, and GI, (eq. 10-10). Gravimetric values 
(III, HI, GI), K, and n from a 1:1 binding isotherm, were 
treated as invariable. Now the data was fit (FIG. 14B) by 
varying the values of the association constants between the 
chiral receptor and the enantiomers of the analyte (K. Ks). 
As a validation to this approach, the association constant 
values obtained from the fitting of the ee curves (see 
captions of FIGS. 14B and 16D) matched very well (the 
errors were less than 5% as shown in Table 5) to the values 
determined from both the traditional competitive binding 
method and the iterative fitting of competitive binding 
curves with enantiomerically pure substrates (Tables 5 and 
9). 
Example 11 
Determination of ee in Phenylactic Acid Samples 
Via Fluorimetry 
To use the K and Ks obtained from the iterative fitting of 
F/F. vs. ee curves for determination of ees of unknown PL 
samples eq. 10-10 was solved. It was found that the asso 
ciation constants obtained by iteration gave more accurate 
results than those extracted from competitive binding curves 
with enantiomerically pure PLs. This may be because some 
of the factors affecting the accuracy of the K and Ks values, 
Such as the variation of ionic strength and Subtle Volume 
changes during the measurements, are kept to a minimum in 
the F/F. vs. ee measurements. As more and more F/F. vs. ee 
data at different concentrations are accumulated, the average 
values of K and Ks obtained with different total analyte 
concentrations will move closer to their true values. 
From the available F/F. vs. ee data (FIG. 14B), 10 data 
points (5 for each concentration) were randomly selected 
and designated as samples with unknown ees. The curves 
were fit with the remaining data points to obtain two sets of 
K. and Ks values. The average K. (3394 M') and Ks (9791 
M") were used in conjunction with other parameters 
(K–31,744 M, II–3.6x10'M', HI-34x10 M', 
G=676x10 M'M' or 1.2x10 M', and n=21.3) ineq. 
10-10 to calculate the ees of the unknown samples based on 
their fluorescence intensity. The determined ee values were 
in good agreement with the actual numbers (Table 6). By 
using fluorimetry and K and Ks values determined from the 
F/F. vs. ee curves, the average error was found to be 7%. 
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ciating with the receptors. However, the extinction coeffi 
TABLE 6 cient of its bound form (e) is too small to enable an actual 
Determination of ees of 10 PL samples by fluorimetry. 
color change. ML absorbs in the UV region, and its appli 
cation as a fluorescent indicator was described in the pre 
Sample No. 5 vious section. In terms of receptors, except for the proline 
derived compounds (17-21) which have no measurable 
1 2 3 4 5 associations to any indicators except ARS, all the others 
Actual ee (G) = 676 M) O.90 O.33 O -0.67 -1.00 have comparable affinities to the indicators (Table 8). 
Determined ee O.92 O.26 -0.13 -0.72 -0.89 The association properties of receptors 11, 12, (S,S)-15, 
Actual ee (G) = 1.2 mM) O.98 0.21 -0.03 -0.38 -0.98 10 and 16 with selective substrates were studied with indicator 
Determined ee 1.02 O.18 -0.09 -0.26 -0.57 displacement assays. PV was selected as the indicator, and 
the association constants are listed in Table 9. Achiral 
receptors 11 and 12 showed no selectivity between enanti 
Example 12 omers of the guest molecules as required by first principles 
15 of stereochemistry. The receptors had stronger affinities 
Displacement with Other Substrates toward ahydroxycarboxylates (e.g. PL and mandelic acid— 
MD) than the vicinal diol hydrobenzoin (HB), which is 
To extend the analyte range of techniques of the inven- consistent with other results.ao Chiral receptor (S,S)-15, 
tion, the affinities between different receptors, indicators and and compound 16 to a lesser extent, displayed enantiose 
guest molecules other than PL were determined via absorp- 20 lectivities toward both a-hydroxycarboxylates and the diol 
tion spectroscopic method. Among all the indicators studied, HB. Another diol studied, 3,4-butanediol, showed no mea 
alizarin red S (ARS) has the largest affinity for the receptors. Surable affinity to 13. Other bifunctional substrates that were 
Generally, the affinities of indicators to a given receptor investigated include b-hydroxyacid (3-hydroxybutyric acid), 
follow the sequence ARS>AC>ML-BR>PV (Table 7). The amino acids (tert-leucine), BINOL, amino alcohol (phenylg 
visible absorption maxima of ARS, AC, and PV undergo 25 lycinol), and ascorbic acid. Ascorbic acid showed consider 
dramatic shifts upon binding with the receptors (Table 7), 
which establish them as effective calorimetric indicators. BR 
also undergoes a large absorption maxima shift when asso 
able affinity via a very slow equilibrium (the color change 
occurs during a course of several hours). All other Substrates 
studied do not appear to associate with the boronic receptors. 
TABLE 7 
Association constants (K/10M) of receptor 11 with various indicators and their 
bathochromicor hypsochromic responses upon association. 
Indicator ARS AC ML PV BR 
batho-/hypsochromic shift/nm 540 -> 456 525 -> 440 294 -> 364 440 -> 480 565 -> 470 
K/10 M-1 50 132 8.7 2.32 8.1 
TABLE 8 
Association constants (K/10M) of boronic receptors (11-21) with indicator AC 
Host 11 12 13 14 (S,S)-15 (R,R)-15 16 17 18. 19 20 21 
K/10 M 13 16 48 22 63 61 S3 1.8 O.94 S7 16 
"Receptors 12-14 do not associate with AC. Their affinities to indicator ARS are shown in 
italics instead. 
TABLE 9 
Association constants (K/10M) of selected receptors with selected substrates 
determined via competitive Spectrophotometric method) and indicator PV. 
PV D-PL L-PL R-MD S-MD (R,R)-HB (S,S)-HB 
11 2.3 1.3 (1.3) 1.3 (1.3) 0.64 O.71 0.54 (0.53) 0.53 (0.50) 
12 3.0 1.6 1.6 O.90 O.93 0.42 (0.48) 0.42 (0.40) 
(S,S)-15 13° 3.4 (2.9) 9.6 (8.4) 2.4 3.0a 0.49 (0.46) 1.3 (1.3) 
16 12 3.1 4.6 2.1 3.2 N.D. N.D. 
Selective association constants obtained from direct iterative curve fitting are shown in the 
parentheses for comparision. 
N.D.: Not determined. 
US 7,332,343 B2 
25 
In order to employ the enantioselective binding of (S,S)- 
15 in a sensing application, a protocol was needed to 
maximize the sensitivity of the assay to the ee variations of 
chiral samples. This included the selection of an indicator, a 
proper concentration for the indicator, and an optimized 
indicator/receptor ratio. It is ideal to have an indicator with 
an affinity between that of two competing analytes 
(K>>Ki->Ko), which are two enantiomers in this 
example. However, this condition cannot always be easily 
met. For example, in this example, the analytes affinities to 
the receptors were generally weaker than that of the indi 
cators (Table 7, 9). Therefore, the indicator PV was chosen 
because its affinity to the receptor was the closest to the 
analytes among all the candidates. In this case, the equilib 
rium H--IH:I was most sensitive to the competition of the 
enantiomeric analytes G and G.s. 
Next, for selecting a proper concentration of the indicator, 
the chiral resolution of an enantioselective indicator-dis 
placement assay at a given analyte concentration and a given 
wavelength was defined as the absorbance difference 
between the enantiomers (DA-Ag-As) for the ease of the 
analysis. DA, the chiral resolution, is a function of K, Ks, 
K., HI, II, etc., as discussed in the last example. A set of 
empirical principles was applied for maximizing the assays 
chiral resolution (AA). When K-Ks and AA=0, the assay 
loses its enantioselectivity. Consequently, the primary factor 
determining the enantioselective response of the assay 
should be the enantioselectivity of the receptor to the 
enantiomers of the analyte. The secondary factor is the 
signal amplifying power (e or (p) of the indicator, which is 
proportional to AA (or AF in a fluorescent assay). Therefore, 
the indicator concentration should be as high as possible 
within the constraint of Beer's Law in order to maximize 
AA. Finally, the assay’s enantioselecting power should 
increase with increasing concentration of the chiral receptor 
(AAOCHI). On the other hand, if the indicator is saturated by 
an excess amount of the receptor, there will be a delayed 
overall response to the analyte, because the analyte will first 
interact directly with the free receptor molecules rather than 
participating in the displacement event. As a result, the 
overall sensitivity of the assay will be reduced. Through 
extensive optimization, it was observed that an HAI ratio 
which gives 75-85% indicator saturation in the absence of 
analytes was best. 
As an example, these empirical criteria were applied in 
the enantioselective binding studies between (S,S)-15 and 
HB. PV was again chosen as the indicator because of its 
weaker affinity—which was relatively close to that between 
HB and (S,S)-15. II, was set at 140 mM where the absor 
bance at 520 nm (the analyzed wavelength) was 1.7 when 
PV was saturated by the receptor (S,S)-15. In the displace 
ment assays, an H, concentration (0.51 mM) was chosen to 
saturate the indicator at an 80% level at the inception. The 
absorbance at 520 nm decreased to different extents upon 
titration of the two enantiomers (FIGS. 16A and 16B). When 
the total analyte concentration (GI) ranged from 4-15 mM, 
the chiral resolution of the enantioselective assay (DA=|A- 
As) was almost constant at 0.25 (FIG.16C). Therefore, this 
assay was optimized for an ee determination when an HB 
sample's total concentration was within 4-15 mM. The 
absorbance (A) vs. ee correlation is shown in FIG. 16D at 














red curve shows that the absorbance at 520 nm, where the 
bound indicator (H:I) absorbs, increases with the growing ee 
of (R,R)-HB (ee) the weaker binding enantiomer. The 
absorbance change as a function of ee (dA/dee) increases 
as the ee is getting larger (FIG. 16D). This is because the 
assay is more responsive to the change of stronger binding 
enantiomer concentration (DGs) when its concentration 
(GI) is relatively small than otherwise. When G, is 
increased to 15 mM, the overall absorption profile (blue) is 
around 0.12 absorbance units lower due to more competitive 
binding, while the other features remain. The assay responds 
to the change of G, and ee similarly to what was observed 
in the fluorescence studies, indicating that the assays behav 
ior reliably follows the laws governing solution multi 
equilibria. 
Seven data points were randomly selected from the two ee 
curves (FIG. 16D) as unknown samples. As described 
above, the curves were fit with the remaining data to 
determine values of K and Ks. The ee values of the seven 
designated unknown HB samples were determined (Table 
10) using a protocol similar to that with fluorimetry 
described in the previous section. The errors were within 
10% of the actual values, except for the one data point that 
was at the least sensitive end of the ee curve. Similar failure 
at Such data region was also observed in the fluorescence 
assay. The nonlinear ee vs. A response originates from the 
different association of two enantiomeric compounds with 
one chiral receptor. In a future development, the enantio 
meric receptor may need to be incorporated into the assay to 
compensate for the accuracy at the low sensitivity end of the 
CUV. 
TABLE 10 
Determination of ees of 7 HB samples by spectrophotometry. 
Sample No. 
1 2 3 4 
Actual ee (G) = 7.5 mM) O.92 O -O.98 
Determined ee O.85 -O.09 -1.09 
Actual ee (G) = 15 mM) O.96 O.82 O -0.82 
Determined ee 1.02 O.88 O.13 -0.59 
The affinities between three substituted pyruvates were 
also studied with indicator-displacement assays, because 
they are the synthetic precursors of C-hydroxycarboxylates 
through hydrogenation. Quite unexpectedly, Substituted 
pyruvates bearing b-proton(s) bound with boronic acid 
receptors such as 11 with various strengths. Apparently the 
enol form of substituted pyruvates led to the formation of 
complexes (FIG. 18). As shown in FIG. 17A, PP and PL 
have comparable affinity to 11. The tautomerization of the 
keto form of PP affords an enolate structure that is stabilized 
through conjugation with the neighboring phenyl ring (FIG. 
18), which leads to a strong association with receptor 11. 
Pyruvic acid (PVA), which lacks the extra stabilization for 
its enol form, displays less, albeit significant affinity to 
receptor 11 (FIG. 17B). Benzoyl formic acid (BF), which 
does not have b-protons and therefore is not able to tau 
tomerize, does not associate with 11 (FIG. 17C). 
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Example 13 
General Methods for ee Determination of C.-Amino 
Acids 
Reagents were obtained from Aldrich and used as 
received unless otherwise noted. Deionized water and 
A.C.S. spectroanalyzed methanol were used to prepare solu 
tions for spectrophotometric titrations. A Varian Unity Plus 
300 MHz spectrometer was used to obtain Hand 'C NMR 
spectra which are referenced to the solvent. A Finnigan VG 
analytical ZAB2-E spectrometer was used to obtain high 
resolution mass spectra. UV/vis spectra were recorded on a 
Beckman DU-640 spectrophotometer. All pH measurements 
were made using an Orion 720A pH meter. 
Synthesis of (S,S)-22 by reductive amination. 
(S,S)-22: To a flame-dried 25 mL round bottom flask was 
added freshly distilled (S,S)-trans-diaminocyclohexane (300 
mg, 2.63 mmol) and 2,5-dimethoxybenzaldehyde (835 mg. 
5.03 mmol). These were dissolved in anhydrous MeOH (4 
mL) and the Solution was stirred under an argon atmosphere 





cooled to 0°C. and NaBH (150 mg, 3.97 mmol) was added. 
After stirring for 1 h, a second portion of NaBH (150 mg) 
was added. The reaction was stirred for an additional 1 h and 
concentrated under reduced pressure to give a white residue, 
which was taken up in CHCl (100 mL) and washed with 
1 M NaOH (2.50 mL). The organic phase was then 
extracted with 1 M HCl (5-50 mL). The pH of the 
combined aqueous phase was adjusted by the addition of 
concentrated NaOH until basic by litmus and was extracted 
with CHCl (5-50 mL). The organic phase was then washed 
with brine (100 mL), dried over NaSO, filtered and 
concentrated to a colorless oil. (685 mg, 65% yield). 
"H NMR (CDC1)TM 6.900 (d. J=2.7 Hz, 2H), 6.731-6.714 
(m, 4H), 3.867 (d. Jx13.5 Hz 2H), 3.724 (s, 6H), 3.703 (s, 
6H), 3.616 (d. J=13.5 Hz 2H), 2.252 (d. J=9.3 Hz, 2H), 
2.133 (d. J=13.8 Hz, 2H), 2.002 (b. 2H), 1.223 (t, J=9.3 Hz, 
2H), 1.073 (t, J=9.3 Hz, 2H); C NMR (CDC1)TM 153.7, 
152.0, 130.6, 115.9, 112.2, 113.3, 61.1, 56.0, 55.9, 46.2, 
20 31.7, 25.3; HRMS (CI, m/z) calcd for CHNO: 
415.25966, found: 415.25968. 
Scheme S-23. The host-indicator association process 
monitored with S-22. 
Scheme S-24. The Indicator Displacement Process Being 
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What is claimed is: 
1. A method of determining in a solution enantiomeric 20 -continued 
Ph Ph 
excess of an analyte having at least one Denantiomer and at 2. 
least one L enantiomer, said method comprising: w 
adding a chiral receptor to the solution, the chiral receptor NH HN 
operable to bind the Denantiomer and Lenantiomer of 25 
the analyte with differing affinities: 
OH HO 
adding an indicator that binds the chiral receptor, the 
indicator operable to change an optical property of the OH HO 
solution when displaced by the analyte; 30 s 
adding the analyte; and NH HN 
observing the optical property, the optical property upon \ K 
displacement of the indicator by the D enantiomer of Ps Ph 
the analyte being detectably different than the optical 35 
property upon displacement of the Lenantiomer of the 
analyte, wherein the chiral receptor is selected from the 
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-continued -continued 
\ \ / 
N O O 
N 5 
B 
Ho Yon O-1 
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NHO OH 10 O 




8 15 (S,S)-22 
OH 2. The method of claim 1, further comprising determining 
HO OH / the enantiomeric excess of the D or Lenantiomer. 
n1 1. 20 3. The method of claim 2, further comprising determining 
the enantiomeric excess through visual analysis. 
4. The method of claim 2, further comprising determining 
the enantiomeric excess through spectrographic analysis. 
as 5. The method of claim 4, further comprising determining 
the enantiomeric excess using an absorbance measurement 
through mathematical analysis. 
6. The method of claim 1, further comprising determining 
the concentration of the analyte. 
30 
7. The method of claim 1, wherein the analyte comprises 
an O-hydroxyacid. 
8. The method of claim 1, wherein the analyte comprises 
a molecule having pharmacological activity. 
9. The method of claim 1, wherein the analyte comprises 
an amino acid. 
10. The method of claim 1, wherein the indicator is 
selected from the group consisting of allZarin red S, allZarin 
40 complexone, 4-methylesculetin, pyrocatechol violet, and 
bromopyrogallol. 
11. A system for determining in a solution enantiomeric 
excess of an analyte having at least one Denantiomer and at 
least one L enantiomer, said system comprising: 45 
a chiral receptor in a solution, the chiral receptor operable 
to bind the D enantiomer and L enantiomer of the 
analyte with differing affinities; and 
an indicator in the solution, the indicator operable to bind 
the chiral receptor and to change an optical property of 
the solution when displaced by the analyte; 
the system operable to allow detection of a first optical 
property upon binding of the D enantiomer to the chiral 
55 receptor and detection of a second optical property upon 
binding of the Lenantiomer to the chiral receptor, wherein 
the chiral receptor is selected from the group consisting of 
60 OMe 
N3/ 27 O 7 - B B OMe 
M \, s V s 
65 HO OH HO OH 
21 1 (S,S)-2 
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HO OH 1 / 
12. The system of claim 11, further comprising the system 
operable to allow detection through visual analysis. 
13. The system of claim 12, further comprising the system 
operable to allow detection through spectrographic analysis. 
14. The system of claim 12, further comprising an achiral 
receptor operable to bind the analyte, the system further 
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operable to allow detection analyte concentration through 17. The system of claim 11, wherein the analyte comprises 
binding of the analyte to the achiral receptor. an amino acid. 
18. The method of claim 11, wherein the indicator is 
selected from the group consisting of allZarin red S, allZarin 
an O-hydroxyacid. 5 complexone, 4-methylesculetin, pyrocatechol violet, and 
bromopyrogallol. 
15. The system of claim 11, wherein the analyte comprises 
16. The system of claim 12, wherein the analyte com 
prises a molecule having pharmacological activity. k . . . . 
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